Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UNG | P13051 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TPMT | P51580 | 3/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.38 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CASP6 | P55212 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA7 | P43166 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2897282 | 0.82 | HPGD (0.48) | ALDH1A1HPGDTPMTALOX15TSHR | |
| SCHEMBL5833655 | 0.82 | HPGD (0.48) | ALDH1A1HPGDTPMTALOX15TSHR | |
| SCHEMBL16434649 | 0.80 | UNG (0.61) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL3470017 | 0.80 | UNG (0.61) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL1174923 | 0.75 | TPMT (0.64) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL15426747 | 0.75 | UNG (0.52) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL17049785 | 0.74 | UNG (0.55) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL17049781 | 0.74 | UNG (0.55) | UNGALDH1A1HPGDTPMTTRIM24 | |
| SCHEMBL18267471 | 0.72 | CA12 (0.62) | UNGALDH1A1HPGDTRIM24TRIM33 | |
| SCHEMBL17167118 | 0.72 | UNG (0.53) | UNGALDH1A1HPGDTPMTTRIM24 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4733297-A1 | INTEGRIN-INHIBITING SMALL MOLECULE COMPOUND | Antibody Therapeutics, Inc. (JP) | 2026-04-29 | — | — | EP | disclosed |
| WO-2024262620-A1 | INTEGRIN-INHIBITING SMALL MOLECULE COMPOUND | 株式会社抗体医学研究所 | 2024-12-26 | — | — | WO | disclosed |
| EP-3960750-B1 | PHOTOSENSITIZING AGENT, AND FLUORESCENT PROBE COMPOSITION | M T 3 INC (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-11643430-B2 | Porphyrin compound or salt thereof, cancer therapeutic agent, photosensitizer, and fluorescent probe | M.T.3, INC. (JP) | 2023-05-09 | — | — | US | disclosed |
| US-20220064203-A1 | COMPOUND OR SALT THEREOF, AND METHOD | M.T.3, INC. (JP) | 2022-03-03 | — | — | US | disclosed |
| EP-3960750-A1 | COMPOUND OR SALT THEREOF, CANCER TREATMENT AGENT, PHOTOSENSITIZING AGENT, AND FLUORESCENT PROBE COMPOSITION | M.T.3, Inc. (JP) | 2022-03-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064203-A1 | COMPOUND OR SALT THEREOF, AND METHOD | RER1, REN, RDX | UNG 4789/4885ALDH1A1 3061/4885HPGD 2363/4885 |
| US-11643430-B2 | Porphyrin compound or salt thereof, cancer therapeutic agent, photosensitizer, and fluorescent probe | PPOX, RB1, HCCS | UNG 4448/4885ALDH1A1 3324/4885HPGD 1522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.